Dr. Marron is an epidemiologist in the field of aging, physical disability, and frailty with a focus on understanding the metabolic etiologies of aging and aging-related disorders. In addition to epidemiology, she has expertise in biostatistics and the biology of aging. Her research involves coupling -omics technologies with epidemiologic and biostatistics methods to identify novel determinants of healthy aging, free from disease and physical disability among population-based cohorts of older adults. She is also interested in investigating racial differences in aging-related health outcomes to determine modifiable factors that explain health disparities and can be targeted to promote health equity with aging. Dr. Marron also teaches Fundamentals of Epidemiological Methods (EPIDEM 2180) and strives to teach in a manner that is understandable to individuals of all knowledge levels, such that every student leaves with a firm understanding of the material.
2011 | Rochester Institute of Technology, Rochester, NY | Bachelor of Science, Applied Statistics
2014 | University of Pittsburgh, Pittsburgh, PA | Master of Science, Biostatistics
2019 | University of Pittsburgh, Pittsburgh, PA | Doctor of Philosophy, Epidemiology
Course Director, EPIDEM 2180: Fundamentals of Epidemiological Methods
1. Metabolomics of integrated markers of aging:
a. Marron MM, Harris TB, Boudreau RM, Clish CB, Moore SC, Murphy RA, Murthy VL, Sanders JL, Shah RV, Tseng GC, Wendell SG, Zmuda JM, Newman AB. Metabolites associated with vigor to frailty among community-dwelling older black men.Metabolites. 2019. 9(5):83.
b. Marron MM, Wendell SG, Boudreau RM, Clish CB, Santanasto AJ, Tseng GC, Zmuda JM, Newman AB. Metabolites associated with walking ability among the oldest old from the CHS All Stars study.J Gerontol A Biol Sci Med Sci. 2020. 75(12):2371-2378.
c. Marron MM, Harris TB, Boudreau RM, Clish CB, Moore SC, Murphy RA, Murthy VL, Sanders JL, Shah RV, Tseng GC, Wendell SG, Zmuda JM, Newman AB. A metabolite composite score attenuated a substantial portion of the higher mortality risk associated with frailty among community-dwelling older adults.J Gerontol A Biol Sci Med Sci. 2021. 76(2):378-384.
2. Developing healthy aging phenotypes:
a. Marron MM, Singh J, Boudreau RM, Christensen K, Cosentino S, Feitosa MF, Minster RL, Perls T, Schupf N, Sebastiani P, Ukraintseva S, Wojczynski MK, Newman AB. A novel healthy blood pressure phenotype in the Long Life Family Study. Journal of hypertension. 2018. 36(1):43-53.
b. Marron MM, Miljkovic I, Boudreau RM, Christensen K, Feitosa MF, Lee JH, Sebastiani P, Thyagarajan B, Wojczynski MK, Zmuda JM, Newman AB. A novel healthy metabolic phenotype developed among a cohort of families enriched for longevity. Metabolism. 2019. 94:28-38.
c.Marron MM, Wojczynski MK, Minster RL, Boudreau RM, Sebastiani P, Cosentino S, Thyagarajan B, Ukraintseva SV, Schupf N, Christensen K, Feitosa M, Perls T, Zmuda JM, Newman AB. Heterogeneity of healthy aging: comparing long-lived families across five healthy aging phenotypes of blood pressure, memory, pulmonary function, grip strength, and metabolism. Geroscience. 2019. 41(4)383-393.
3. Racial disparities in health with aging:
a.Marron MM, Wendell SG, Boudreau RM, Clish CB, Santanasto AJ, Tseng GC, Zmuda JM, Newman AB. Metabolites associated with walking ability among the oldest old from the CHS All Stars study. J Gerontol A Biol Sci Med Sci. 2020. 75(12):2371-2378. doi:10.1093/gerona/glaa030
b. Jacob ME,Marron MM, Boudreau RM, Odden MC, Arnold AM, Newman AB. Age, Race, and Gender Factors in Incident Disability. J Gerontol A Biol Sci Med Sci. 2018. 73(2):194-197.
c. Marron MM, Moore SC, Wendell SG, Boudreau RM, Miljkovic I,Sekikawa A, Newman AB. Using lipid profiling to better characterize metabolic differences in apolipoprotein E (APOE) genotype among community-dwelling older Black men.Geroscience. 2021. [Online ahead of print]. doi: 10.1007/s11357-021-00382-6.
Complete list of published work in MyBibiography:
https://www.ncbi.nlm.nih.gov/myncbi/1j1Zl9oL55t5w/bibliography/public/
